Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLC
| Image |  |
|---|---|
| Description | scientific article published on 31 January 2019 |
| Author/s |
author: Enriqueta Felip Roy S. Herbst |
| Publication date | January 31, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |